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ABSTRACT
The aim of this study was to compare titania (TiO2)-coated, titania-silica (TiSi)-coated, and uncoated
(cpTi) titanium fiber meshes as scaffolds for bone engineering. The scaffolds were loaded with bone
marrow stromal cells and implanted subcutaneously in rats. Ectopic bone formation after 1, 4, and
12 weeks of implantation was evaluated using histology and histomorphometry. After 1 week of implan-
tation, multiple patches of unorganized mineralizing tissue were seen in all implants. The amount of this
bone-like tissue clearly increased from 1 to 4 weeks. Bone apposition occurred in direct contact with coated
meshes, while a thin layer of unmineralized fibrous tissue was often observed surrounding cpTi mesh
fibers. After 12 weeks, the structure of bone, with bone marrow–like tissue, was further matured and mesh
fibers were embedded in lamellar bone. No statistical differences in the amount of mineralized bone were
observed between scaffold types at any point of time. Only TiSi scaffolds showed further increase in bone
area from 4 to 12 weeks ( p< 0.01). A notable difference was that the sol-gel coatings resulted in enhanced
initial bone contact and distribution of bone tissue, whereas uncoated implants showed bone formation
mainly in the center of the scaffolds. In conclusion, TiO2-based sol-gel coatings may be used in tissue
engineering to gain more uniform distribution of bone throughout titanium fiber mesh scaffolds.
INTRODUCTION
BONE GRAFTS ARE OFTEN USED to reconstruct bone defects,and autogenous grafts are considered a golden standard
in the procedure. However, the use of autogenous bone
grafts is restricted by donor-site morbidity and the additional
surgical procedure under general anesthesia needed for
harvesting the graft. This is an important aspect as most of
the patients are at an advanced age and the use of autogenous
bone grafts is impossible in many of them. Hence new
strategies to reconstruct bone defects are urgently needed.
Tissue engineering strategies can be utilized in many cases
of bone reconstruction provided that proper scaffold mate-
rials are available.1–3
In cell-based bone engineering strategies, osteogenic cells
are incorporated into implanted scaffolds to supply adequate
cells for tissue regeneration. These may be stem cells or
progenitor cells capable of producing bone tissue and bone-
inducing growth factors. The most common source of cells
are mesenchymal stem cells derived from bone marrow.
These cells can be expanded and induced to osteogenic
lineage in vitro to obtain a suitable cell population for further
in vivo applications.4,5
Ectopic implantation is a widely used method to assess
biological response to bone engineering constructs. The ef-
fects of scaffold properties on bone formation can be sys-
tematically evaluated in comparative studies using multiple
scaffold types. Such experiments have been conducted to
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analyze the importance of, for example, porous design6–8
and bulk9–12 or surface13,14 chemistry of the scaffolds.
Sintered titanium fiber mesh loaded with bone marrow
stromal cells has previously been used as a mechanically
strong bone graft substitute.15 However, meshes that are not
loaded with cells show only minor osteoconductive proper-
ties. Proposed methods to increase the osteoconductivity of
titanium metal include alkali-heat treatment,16 anodic oxi-
dation,17–19 and use of sol-gel-derived titania (TiO2) coat-
ings.20 Sol-gel dip-coating method can be used to produce
nanoporous TiO2 surface on commercially pure titanium, and
such thin films have been found to induce calcium phosphate
precipitation on their surface.21 Further, the bioactivity of
silica-containing bioceramics22 has led to the development
of mixed titania-silica (TiSi) coatings.23 Indeed, the osteo-
blast response on planar surfaces,24 but not in porous scaf-
folds,25 was found to be enhanced by incorporation of a
reactive silica phase in the TiO2 coating. We therefore
hypothesize that nonresorbable bioactive coatings based on
TiO2, with or without a silica phase, can enhance bone for-
mation in vivo.
The aim of the current study was to compare ectopic bone
formation in rats with TiO2-coated, TiSi-coated, and un-
coated implants loaded with bone marrow stromal cells. This
is the first time that such coated tissue engineering scaffolds
are tested in vivo. Bone formation after 1, 4, and 12 weeks of
implantation was evaluated using histology and histomor-
phometry.
MATERIALS AND METHODS
Scaffold preparation
A sintered titanium fiber mesh (Bekaert N.V., Zwevegem,
Belgium) with a volumetric porosity of 86%, a density of
600 g/m2, a fiber diameter of 40 mm, and an average distance
between fibers of 250 mm was used. Of this mesh, disc-
shaped specimens 6 mm in diameter and 0.8 mm thick were
cut, and used as such (cpTi), or coated with TiO2 or a 30:70
mol% mixture of titania and silica (TiSi) using a previously
described sol-gel technique.25
Briefly stated, the titanium fiber mesh substrates were
cleaned ultrasonically in acetone and ethanol (5þ 5 minutes),
and dried in air before each dipping and heating cycle. The
two different coatings were achieved by dipping the sub-
strates into respective sols and then withdrawing them at a
speed of 0.3 mm/second. The substrates were then heated
at 5008C for 10 minutes. The dipping and heating cycle was
repeated five times. Uncoated and coated scaffolds were fi-
nally cleaned ultrasonically and sterilized using gamma ra-
diation (25 kGy minimum).
Cell culture and implant preparation
Rat bone marrow was harvested and cultured according to
the procedure given by Maniatopoulos et al.26 Briefly said,
the femurs of four 6-week-old male adult (100 –110 g) syn-
geneic Fisher 344 rats (F344/NHsd, Harlan, the Netherlands)
were retrieved directly after the animals were sacrificed. The
bones were wiped with 70% alcohol and immersed twice in
alpha-minimum essential medium (alpha-MEM) (Sigma
Chemical, St. Louis, MO) culture medium containing 100
units/mL of penicillin/streptomycin (Gibco BRL, Life Tech-
nologies BV, Breda, the Netherlands). The condyles were
cut off and bone marrow was flushed out using complete cell
culture medium (alpha-MEM, antibiotics supplemented with
15% fetal bovine serum (Gibco), 50 mg/mL ascorbic acid
(Sigma), 8.5 mM Na-b-glycerophosphate (Merck, Darm-
stadt, Germany), and 10 nM dexamethasone (Sigma)). The
resulting suspension was passed through a 22 G needle, and
plated cells were cultured in a humidified 5% carbon dioxide
(CO2) atmosphere at 378C.
After 7 days of primary culture, the adherent osteoblast-
like cell population was enzymatically detached (0.25%
trypsin/0.02% EDTA (Sigma)), and a stock of 1.5106 cells/
mL was prepared in complete culture medium. Titanium
fiber meshes were incubated in complete medium for 3 hours
before cell suspension (*0.15 mL per mesh) was added to
each type of substrate in polypropylene tubes. Cells were
allowed to adhere at 378C for 2.5 hours under continuous
rotation (6 rpm). Substrates were subsequently transferred to
24-well plates and cultured overnight. The next day, sub-
strates were placed into serum-free medium and translocated
to the animal facility. Substrates were kept at 378C during
surgery, and washed with phosphate buffered saline before
implantation.
Implantation procedure
For implantation, eighteen 3-week-old male (25 to 40 g)
syngeneic Fisher 344 rats were used. The experiment was
approved by the Lab-Animal Care & Use Committee at the
University of Turku, Finland (licence #953/99). Experiment
was conducted in good laboratory practice (GLP) compliant
laboratory animal facilities, and national and European regu-
lations for animal experimentation were followed. Operations
were performed under general anesthesia induced by subcu-
taneous injection of fentanyl citrate/fluanisone (Hypnorm,
Janssen Pharmaceutica, Beerse, Belgium) and midatzolam
(Dormicum, Roche, Basel, Switzerland). The operation area
was shaved and disinfected with chlorhexidine gluconate so-
lution (Klorhexol, Leiras, Turku, Finland).
Subcutaneous implantation was performed through two
longitudinal incisions in the midline of the dorsal skin. In-
dividual implant beds were prepared by blunt dissection.
Each animal received one of each implant type (total three).
One implant was placed on the left and two on the right flank
of the animals using Latin Square randomization scheme.
Skin wounds were closed in two layers with individual resorb-
able sutures (Vicryl 3-0, Johnson & Johnson, Brussels,
Belgium). The animals were sacrificed after 1, 4, and 12
weeks using CO2 suffocation. Implants were retrieved with 2
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to 4 mm soft tissue margin, and fixed in 4% buffered for-
malin at 88C for 2 weeks.
Histological sections and
histomorphometrical evaluation
Fixed specimens were dehydrated in a graded series of
ethanol and embedded in methylmethacrylate. After poly-
merization, three 10 mm thick sections were prepared per
implant, using a modified sawing microtome technique.27
Sections were double stained with methylene blue and basic
fuchsine.
Sections were histologically evaluated for bone morphol-
ogy, fibrous tissue capsule formation, inflammatory reac-
tion, and foreign body reaction, using light microscopy. The
lamellar structure of remodeled bone was evaluated using
polarizing microscopy. Computer-based histomorphome-
trical analysis (using Leica QWin Standard v3.0 software)
was performed to determine the cross-sectional area of the
scaffold material and of the newly formed bone in the im-
plants. The distribution of bone within scaffolds was ana-
lyzed by dividing the implant area into the outermost 200 mm
boundary layer and the remaining interior part. An average
of the measurements from three sections per implant was
used for the statistical analysis.
Statistics
Statistical analyses were performed using the SPSS v11.0
software package (SPSS, Chicago, IL). Data were analyzed
with one-way ANOVA followed by Tukey’s post hoc test.
Differences were considered significant at a 95% confi-
dence level.
RESULTS
Implant retrieval
Four animals did not recover from the operation and were
lost from the follow-up during the first two postoperative
days. Healing was uneventful for the remaining 14 animals,
and they were sacrificed at 1 (n¼ 4), 4 (n¼ 5), and 12 (n¼ 5)
weeks of implantation. At retrieval no clinical signs of in-
flammation or adverse reactions were observed. All implants
were surrounded by a thin reaction-free fibrous tissue capsule.
Descriptive light microscopy
One week implants. In coated implants the smallest pores
were partially occluded by sol-gel aggregates. TiO2 aggre-
gates had a granular appearance, while TiSi aggregates
formed a more continuous phase. One cpTi and one TiO2
scaffold were partially filled by a resolving hematoma caused
by excessive bleeding during implantation, and they were
excluded from the subsequent histomorphometrical analysis.
After 1 week of implantation, a few mononuclear leuco-
cytes were observed in and around the scaffolds. All scaf-
folds were surrounded by loosely aligned connective tissue
that formed a 4–10 cell layers thick capsule. The scaffolds
were already filled with well-vascularized loose fibrous
connective tissue. Multiple patches of unorganized miner-
alizing tissue with scarce amounts of woven bone were
seen in all implants (Fig. 1). Most of the mineralization was
on the periphery of the scaffolds, and it was more abundant
on the dorsal than on the ventral side. More number of sites
with osteoblast-like cells and osteoid tissue expressing ac-
tive bone formation were observed within TiO2 and cpTi
scaffolds than within TiSi scaffolds.
Four week implants. Fibrous tissue in and around the
scaffolds was more organized and contained more collagen
fibers compared to 1 week implants. The number of mono-
nuclear inflammatory cells was comparable to that observed
in 1 week implants. Occasional multinuclear cells were
FIG. 1. Bone formation at 1 week of implantation. Bone for-
mation within cpTi scaffolds (above) was typically observed be-
tween the titanium fibers (white asterisks), whereas within coated
scaffolds (below) bone formed directly on the surface of the fibers.
Rounded osteoblast-like cells (black arrowheads) are seen on the
surface of woven bone (WB). Scale bar 100mm. Color images avail-
able online at www.liebertpub.com/ten.
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FIG. 2. Typical patterns of bone formation within subcutaneously implanted cpTi (left column), TiO2 (center column), and TiSi (right
column) scaffolds. Sections at each time point are from the same animal. After 1 week, multiple patches of unorganized mineralizing tissue
with scarce amounts of woven bone were seen in all implants. The amount of bone-like tissue clearly increased from 1 to 4 weeks. After
12 weeks the structure of bone, with bone marrow–like tissue, was further matured and mesh fibers were embedded in lamellar bone, which
can be clearly seen with polarizing microscopy (Pol). Scale bar 200 mm. Color images available online at www.liebertpub.com/ten.
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observed with all scaffold types, slightly more with coated
scaffolds than with uncoated scaffolds. However, the num-
ber of multinuclear cells observed in all implants was within
the range of 0–5 cells/section. The appearance of sol-gel
aggregates within coated scaffolds was similar to that no-
ticed in 1 week implants.
The amount of bone-like tissue clearly increased from 1 to
4 weeks with all scaffold types. Large areas of mineralized
matrix with embedded osteocytes were observed. On the
surface of the deposited bone, osteoid, active plump osteo-
blasts, and flattened lining cells as well as occasional re-
sorption pits could be seen. With cpTi and TiO2 scaffolds,
bone tissue formed large, continuous areas, while with TiSi
scaffolds bone still existed in multiple discrete areas inter-
spersed with fibrous tissue. Three out of five cpTi scaffolds
also contained diverse amounts of adipose tissue at their
periphery. In contrast, the bone within two TiO2 scaffolds
exhibited large cavities filled with fibrous and adipose tissue,
but no fatty tissue was seen outside the bone. Further, these
scaffolds showed bone formation not only inside the im-
plants but also on their outer surface. No fatty tissue was
observed within any of the TiSi scaffolds. Bone apposition
occurred in direct contact with sol-gel-coated meshes, while
a thin layer of unmineralized fibrous tissue was often ob-
served surrounding the cpTi mesh fibers (Fig. 2). Also, direct
bone formation was seen on larger sol-gel aggregates while
small, discrete sol-gel particles were surrounded by fibrous
connective tissue.
Twelve week implants. The appearance of the fibrous
capsule or the sol-gel aggregates, and the number of in-
flammatory and multinuclear cells had not changed from 4 to
12 weeks. Fibrous tissue inside the scaffolds was mostly re-
placed by adipose tissue that typically formed discrete areas
within mineralized tissue, resembling bone marrow. The
structure of bone was further matured and contained larger
areas of remodeled lamellar bone. A layer of flattened cells
covered the bone surface, and rounded osteoblasts were
almost absent. Numerous resorption pits were observed in
all specimens (Fig. 3). With all scaffold types, direct bone-
titaniumcontactwasobservedwhentitaniummeshfiberswere
embedded within bone. With cpTi and TiO2 scaffolds, more
bone marrow–like tissue within bone cavities were observed
than before. The structure of bone tissue with TiO2 scaffolds
even resembled that of cancellous bone. With TiSi scaffolds
the amount of bone tissue had increased, and the previously
discrete areas of bone were growing together. Some fibrous
tissue could be seen at the periphery of the scaffolds, while
the cavities in bone were almost exclusively filled with bone
marrow–like tissue. Three TiO2 and all TiSi scaffolds
showed some bone formation also on their outer surface.
Histomorphometry
For the histomorphometrical analysis only stained miner-
alized tissue within the scaffolds was defined as bone (Fig. 4).
Results of bone formation within the whole implant area are
summarized in Table 1. After 1 week of implantation, bone
formation was very limited with all scaffold types. However,
significantly more bone was observed with cpTi than with
TiSi scaffolds ( p< 0.05). At 4 weeks, the amount of bone
had increased to approximately 15%, 13%, and 10% for
cpTi, TiO2, and TiSi scaffolds, respectively, with no statis-
tical differences between scaffold types. Only TiSi scaffolds
showed further increase in bone area by 12 weeks (p< 0.01).
At that time the bone areas were 18%, 16%, and 21%, re-
spectively, and the difference between TiO2 and TiSi scaf-
folds was statistically significant (p< 0.05).
The sol-gel aggregates resulted in the decrease of mea-
sured porosity within coated scaffolds by approximately 10%
(data not shown). Bone formation within open porosity of the
implants is summarized in Table 2. Again, a five to ten times
increase in bone formation was noticed from 1 to 4 weeks for
all scaffold types, and TiSi scaffolds were the only ones
showing further increase in pore filling from 4 to 12 weeks
( p< 0.01). No statistically significant differences between
scaffold types were observed at any time of implantation.
The distribution of bone within scaffolds changed during
the implantation period (Table 3). At 1 week, most of the min-
eralization was found within the outermost 200 mm bound-
ary layer of the scaffolds (corresponding altogether to 50%
of the implant thickness and 60% of the implant area). At
4 weeks the situation had reversed, and only 20–30% of bone
existed in the periphery of the scaffolds. No great change in
bone distribution occurred from 4 to 12 weeks, but the dif-
ference between cpTi and TiO2 scaffolds became statisti-
cally significant. This corresponded to histological findings,
which showed more even distribution of bone-like tissue
FIG. 3. Bone remodeling at 12 weeks within TiO2 scaffold. Bone
and fibroconnective tissue with blood vessels (black asterisks) are
seen between the titanium fibers (white asterisks). Lamellar bone
(LB) with embedded osteocytes is covered by flattened lining cells
(black arrowheads). Several resorption pits (black arrows) were
also observed. Scale bar 100 mm. Color images available online at
www.liebertpub.com/ten.
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within sol-gel-coated scaffolds compared to the uncoated
scaffolds.
DISCUSSION
It has been shown that cell-loaded titanium fiber scaffolds
have bone-forming potential in ectopic rat models.28,29 Bone
formation further increases when calcium phosphate–coated
scaffolds are used.14 However, such coatings are ultimately
resorbed in vivo, exposing the underlying metal surface and
potentially resulting in the loss of existing contact with
surrounding tissues.30 On the other hand, nonresorbable sol-
gel TiO2 coatings have been shown to increase both bone
20
and soft-tissue31 attachment to titanium implants. Under cul-
ture conditions, osteoblast response on planar surfaces,24 but
not in porous scaffolds,25 was found to be further enhanced
by incorporation of a reactive silica phase in the coating. We
therefore hypothesized that nonresorbable bioactive coat-
ings, with or without a silica phase, have good potential to
enhance ectopic bone formation. We set out to study bone
formation on sol-gel-coated titanium fiber mesh scaffolds
loaded with osteoprogenitor cells in rat subcutaneous envi-
ronment.
In our previous studies, sol-gel-derived coatings have
been prepared using a dipping method.23–25 This method,
however, is not optimal for porous substrates because the
high viscosity of the coating sols may result in uneven coating
thickness on scaffold surfaces. This was also noticed in the
present study as we found a large amount of aggregated
coating material inside the TiO2 and TiSi scaffolds. Al-
though the aggregates did not seem to result in particle-
induced inflammation, they did alter the pore size distribu-
tion and the porous structure of the meshes. This reduces the
permeability of the scaffold and occludes some of the
smallest pores. More controlled coatings are thus preferred.
This could possibly be achieved by lowering the viscosity of
the coating sols, by reducing the number of coating layers, or
by removing the excess sol by centrifugal force before heat
treatment. In other words, for future work, spin coating might
be more suitable for porous scaffolds than the traditional
dip-coating technique used in the current study setup.32,33
The scaffolds were seeded with cells using a previously
optimized protocol.28,34 The harvested bone marrow stromal
cells were precultured in the presence of dexamethasone to
allow for their early differentiation toward the osteogenic lin-
eage. The osteoblasts were loaded in suspension to achieve a
uniform distribution of cells throughout the scaffolds. The
cells were subsequently allowed to attach and spread only for
1 day prior to implantation, as this results in more active bone
formation than longer culture periods. However, significantly
longer cultures of cell-scaffold constructs will be needed if
the precultures are performed without dexamethasone.35,36
Much higher ectopic bone formation with uncoated tita-
nium scaffolds was observed in this study (15% to 18%)
than in our previous research (less than 10%) using similar
FIG. 4. Distribution and amount of bone within cpTi (left column), TiO2 (center column), and TiSi (right column) scaffolds. For
histomorphometric analysis the percentage of mineralized tissue was measured within the whole titanium fiber mesh and within the open
porosity. Mineralization can be seen in the periphery of the scaffolds at 1 week. Later, the amount of bone increased and it was more
evenly distributed. Only coated scaffolds showed bone also on their outer surfaces. Scaffolds are 6 mm in diameter and 0.8 mm thick.
Color images available online at www.liebertpub.com/ten.
TABLE 1. CROSS-SECTIONAL AREA OF BONE WITHIN WHOLE IMPLANTS
DURING 12 WEEKS OF IMPLANTATION
cpTi TiO2 TiSi p< 0.05
1 week 3.0 0.4%a 1.5 1.4%a 0.8 0.5%b cpTi>TiSi
4 weeks 15.0 3.9% 12.7 4.6% 9.9 2.6% NS
12 weeks 18.4 1.5% 16.1 2.7% 20.7 2.1% TiO2<TiSi
p< 0.01 1 wk< 4 wk 1 wk< 4 wk 1 wk< 4 wk< 12 wk
n¼ 5 if not otherwise stated; an¼ 3, bn¼ 4
NS¼Not significant
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experimental protocol.29,37 The degree of osteogenic dif-
ferentiation in primary bone marrow stromal cell cultures is
subject to variation, and the initial phenotype of seeded cells
is known to affect the amount of ectopic bone formation.38,39
This can possibly explain the discrepancy between our own
experiments. No definitive answer can be given, however,
and it emphasizes the difficulties in comparing results from
different studies, and the importance of using relevant con-
trol samples in all experiments.
The amount of bone within the whole implant area, as well
as within the open porosity, did not show substantial dif-
ferences, but the kinetics of bone formation differed between
scaffold types. With cpTi and TiO2 scaffolds the maximal
amount of bone was reached already after 4 weeks of im-
plantation, whereas bone formation with TiSi scaffolds con-
tinued throughout the experiment. TiO2 scaffolds seemed to
show the most active bone formation and remodeling. In-
terestingly, at the level of light microscopic evaluation, ec-
topic bone formation occurred directly on the TiO2- and
TiSi-coated titanium, as well as on larger sol-gel aggregates
at all times. Such behavior resembles ectopic bone formation
within porous calcium phosphate ceramics, and indicates
good attachment of seeded cells to the underlying sub-
strate.40,41 In contrast, bone formation within cpTi meshes
usually started away from the titanium surface, and individ-
ual fibers were mostly surrounded by a thin layer of fibrous
unmineralized tissue still at 4 weeks. As bone formation
proceeded, and mesh fibers were embedded in bone matrix,
all materials showed good bone contact.
Bone seemed to grow out from multiple starting points,
as indicated by individual mineralizing tissue patches at
1 week. Further, discrete bony areas were observed within
TiSi scaffolds even after 4 weeks of implantation. In addi-
tion to direct material effects, decreased cell-seeding effi-
ciency might also have contributed to the delayed bone
formation within TiSi scaffolds.42 However, this aspect was
not analyzed in the current study. When the amount of bone
increased, a more continuous tissue was formed, irrespec-
tive of the scaffold type. Mineralization began from the pe-
riphery of scaffolds, where the amount of seeded cells was
likely to be the highest and diffusion limitations the lowest.
However, almost every specimen showed ingrowth of well-
vascularized connective tissue through the mesh already at
1 week. This is very important for the survival of seeded
cells and for the subsequent bone formation.43,44 Later bone
formation was most evident in the middle of the scaffolds,
and bone grew in direct contact with mesh fibers, with no
intervening fibrous tissue. Coated scaffolds showed en-
hanced osteoconductivity and more dispersed bone forma-
tion than the uncoated ones. Similar results were recently
obtained when uncoated titanium mesh was compared with a
calcium phosphate ceramic.37 Bone formation on the outer
surface of only the sol-gel-coated scaffolds further advocates
their increased osteoconductivity. Again, this finding re-
semblesectopicboneformationwithinceramicscaffolds.45,46
Subsequently, the coatings should also be tested in an or-
thotopic site to analyze their behavior more precisely.
CONCLUSIONS
The amount of ectopic bone formed with bone mar-
row stromal cell–seeded TiO2- and TiSi-coated scaffolds
was comparable to that with uncoated titanium scaffolds.
However, differences were observed in the kinetics of bone
formation, and at the implant-bone interface. A notable
TABLE 2. CROSS-SECTIONAL AREA OF BONE WITHIN OPEN POROSITY
DURING 12 WEEKS OF IMPLANTATION
cpTi TiO2 TiSi p< 0.05
1 week 5.0 0.4%a 3.0 2.6%a 1.6 1.2%b NS
4 weeks 23.9 5.8% 23.0 5.5% 16.4 3.6% NS
12 weeks 25.9 1.6% 27.3 7.0% 34.1 5.3% NS
p< 0.01 1 wk< 4 wk 1 wk< 4 wk 1 wk< 4 wk< 12 wk
n¼ 5 if not otherwise state; an¼ 3, bn¼ 4
NS¼Not significant
TABLE 3. FRACTION OF BONE IN THE OUTERMOST 200 mM BOUNDARY LAYER OF THE SCAFFOLDS
cpTi TiO2 TiSi p< 0.05
1 week 72.2 9.5%a 68.8 18.0%a 84.5 15.3%b NS
4 weeks 22.9 11.3% 32.1 7.9% 29.8 12.8% NS
12 weeks 24.5 7.1% 43.1 8.8% 35.7 6.7% cpTi<TiO2
p< 0.01 1 wk> 4 wk 1 wk> 4 wk 1 wk> 4 wk
n¼ 5 if not otherwise state; an¼ 3, bn¼ 4
NS¼Not significant
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difference was that the sol-gel coatings resulted in bone
formation throughout the implants, whereas uncoated im-
plants showed bone formation mainly in the center of the
scaffolds.
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